These findings support the literature evidence pointing to an increase in PPAR-γ expression through its activation by pioglitazone, emphasizing this receptor’s correlation with obesity-related adipogenesis [7]. The gene discussed is PPARG; the disease is obesity due to melanocortin 4 receptor deficiency.